SCHEMBL14347879

SCHEMBL14347879

Cc1ccc(C2(CCNC3CC3)CCCC2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 7/20 0.43
SLC6A3 Q01959 6/20 0.43
SLC6A2 P23975 4/20 0.43
KDM4E B2RXH2 1/20 0.43
OPRM1 P35372 1/20 0.40
LMNA P02545 4/20 0.36
ALDH1A1 P00352 3/20 0.36
NPSR1 Q6W5P4 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
GAA P10253 1/20 0.36
ICMT O60725 2/20 0.35
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HTT P42858 1/20 0.34
HTR1A P08908 1/20 0.34
HTR7 P34969 1/20 0.34
HTR6 P50406 1/20 0.34
MEN1 O00255 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8353652 0.97 KDM4E (0.43) SLC6A4SLC6A3SLC6A2KDM4EOPRM1
SCHEMBL8353178 0.94 KDM4E (0.42) SLC6A4SLC6A3SLC6A2KDM4EOPRM1
SCHEMBL8350796 0.84 SLC6A4 (0.60) SLC6A4SLC6A3SLC6A2KDM4ELMNA
SCHEMBL14347887 0.80 SLC6A4 (0.47) SLC6A4SLC6A3SLC6A2OPRM1LMNA
Hydrochloric Acid SCHEMBL11113043 0.80 SLC6A4 (0.46) SLC6A4SLC6A3SLC6A2OPRM1LMNA
SCHEMBL8353430 0.78 SMN1; SMN2 (0.42) SLC6A4SLC6A3SLC6A2OPRM1LMNA
SCHEMBL8353273 0.77 SLC6A4 (0.51) SLC6A4SLC6A3SLC6A2KDM4ELMNA
SCHEMBL14347859 0.77 SLC6A4 (0.44) SLC6A4SLC6A3SLC6A2OPRM1LMNA
SCHEMBL8353668 0.76 SLC6A4 (0.51) SLC6A4SLC6A3SLC6A2KDM4ELMNA
SCHEMBL8354044 0.76 SLC6A4 (0.51) SLC6A4SLC6A3SLC6A2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312214-B2 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-12-25 US disclosed